Sulbactam‐durlobactam: A novel β‐lactam‐β‐lactamase inhibitor combination targeting carbapenem‐resistant <i>Acinetobacter baumannii</i> infectionsAmer El Ghali, Michael J. Rybak|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2023Cited by 50